Improving AAV Gene Therapy Safety Analysis: Multiplex LAM-PCR Provide New Insights Into AAV Vector Integration

被引:0
|
作者
Gil-Farina, Irene [1 ]
Kaeppel, Christine [1 ]
Wilkening, Stefan [1 ]
Lopez-Franco, Esperanza [2 ]
Paneda, Maria Astrid [3 ]
Prieto, Jesus [4 ]
Spronck, Lisa [5 ]
von Kalle, Christof [1 ]
Petry, Harald [5 ]
Gonzalez-Aseguinolaza, Gloria [2 ]
Schmidt, Manfred [1 ]
机构
[1] NCT DKFZ, Translat Oncol, Heidelberg, Germany
[2] CIMA, Gene Therapy & Hepatol, Pamplona, Spain
[3] DIGNA Biotech SL, Madrid, Spain
[4] Univ Hosp Navarra, Pamplona, Spain
[5] uniQure, Amsterdam, Netherlands
关键词
D O I
10.1016/S1525-0016(16)34273-3
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
664
引用
收藏
页码:S264 / S264
页数:1
相关论文
共 41 条
  • [41] Single-intrathecal delivery of a new AAV9-mediated gene therapy vector provides long-term safe expression of frataxin and prevents neurological and cardiac deficits, neurodegeneration and iron deposition in a Friedreich's Ataxia mouse model
    Balague, E.
    Cota-Gonzalez, D.
    Adrian-Campbell, K.
    Garcia-Lareu, B.
    Bosch, A.
    Coll-Canti, J.
    Chillon, M.
    Sanchez, I.
    Matilla-Duenas, A.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2020, 28 (SUPPL 1) : 89 - 90